Related Experiment Videos
[Peritoneal dialysis in patients with polycystic kidneys]
N B Pavlović1, S Stojacnov, S Ljubenović
1Institute of Nephrology, University School of Medicine, Nish.
Srpski Arhiv Za Celokupno Lekarstvo
|January 1, 1996
Summary
Peritoneal dialysis (PD) can be a successful treatment for selected patients with end-stage polycystic kidney disease (PKD). While complications like increased blood pressure and hypocalcemia occurred, PD offered a viable option for these patients.
Area of Science:
- Nephrology
- Urology
Background:
- Polycystic kidney disease (PKD) is generally considered a contraindication for peritoneal dialysis (PD).
- End-stage kidney disease (ESKD) necessitates renal replacement therapy.
Purpose of the Study:
- To evaluate the efficacy and safety of peritoneal dialysis in patients with end-stage polycystic kidney disease.
- To determine if PD is a viable treatment option for selected ESKD patients with PKD.
Main Methods:
- A cohort of 10 end-stage kidney disease patients with polycystic kidney disease were treated with peritoneal dialysis.
- Treatment included both intermittent peritoneal dialysis (4 patients) and continuous ambulatory peritoneal dialysis (6 patients).
Main Results:
- Peritoneal dialysis was successful in the majority of the treated patients.
- Observed complications included a significant increase in arterial blood pressure in one patient.
- Other complications included hypocalcemia-induced epileptiform seizures (three instances) and the diagnosis of renal cancer in one patient after two months of PD.
Conclusions:
- Peritoneal dialysis can be a successful treatment modality for carefully selected patients with end-stage polycystic kidney disease.
- Despite potential complications, PD offers a feasible alternative for renal replacement therapy in this patient population.